A comparison of the experimental and theoretical charge density distributions in two polymorphic modifications of Piroxicam. by Lai, Felcia et al.
1	  	  
A comparison of the experimental and theoretical charge density distributions in two 
polymorphic modifications of Piroxicam. 
 
Felcia Lai,1 Jonathan J. Du,1 Peter A. Williams,1,2 Linda Váradi,1 Daniel Baker,3 Paul 
W. Groundwater,1 Jacob Overgaard,4 James A. Platts5 and David E. Hibbs1* 
  
1Faculty of Pharmacy, The University of Sydney, NSW 2006 Australia 
2School of Science and Health, Western Sydney University, Locked Bag 1797, Penrith, NSW, 
2751 
3Rigaku Oxford Diffraction, Oxford Industrial Park, Yarnton, Oxfordshire, OX5 1QU, UK 
4Department of Chemistry, Center for Materials Crystallography, Aarhus University, 
Langelandsgade 140, Aarhus C, 8000, Denmark 
5School of Chemistry, Cardiff University, P.O. Box 912, Cardiff, CF13TB (Wales) 
 
*Corresponding author: David E. Hibbs, david.hibbs@sydney.edu.au 
 
 
 
 
 
 
 
 
 
 
 
2	  	  
 
Abstract  
Experimental charge density distribution studies of two polymorphic forms of piroxicam, β-
piroxicam (1) and piroxicam monohydrate (2), were carried out via high-resolution single 
crystal X-ray diffraction experiments and multipole refinement. The asymmetric unit of (2) 
consists of two discrete piroxicam molecules, (2a) and (2b), and two water molecules. 
Geometry differs between (1) and (2) due to the zwitterionic nature of (2) which results in the 
rotation of pyridine ring around the C(10)–N(2) bond by approximately 180°. Consequently, 
the pyridine and amide are no longer co-planar and (2) forms two exclusive, strong hydrogen 
bonds, H(3) …O(4) and H(2) …O(3), with bond energy of 66.14 kJ mol-1 and 112.82 kJ mol-
1 for (2a), 58.35 kJ mol-1 and 159.51 kJ mol-1 for (2b) respectively. Proton transfer between 
O(3) and N(3) in (2) results in significant differences in surface electrostatic potentials. This 
is clarified on calculation of atomic charges in the zwitterion shows the formally positive 
charge of the pyridyl nitrogen is redistributed over the whole of the pyridine ring instead of 
concentrated at N-H. Similarly, the negative charge of the oxygen is distributed across the 
benzothiazinecarboxamide moiety. Multipole derived lattice energy for (1) is -304 kJ mol-1 
and that for (2) is -571 kJ mol-1, which is in agreement with the experimentally determined 
observations of higher solubility and dissolution rates of (1) compared to (2). 
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Introduction  
Polymorphism occurs when a compound exists in different crystal forms with the same 
chemical composition. In the past century, polymorphism of organic compounds, active 
pharmaceutical ingredients (API) in particular, has been extensively studied. At present, most 
pharmaceutical products are formulated in solid form, providing accurate dosage and easy 
storage but over half of these exhibit polymorphism.1 The inconsistencies in physical 
properties displayed by pharmaceutical polymorphs, especially dissolution rate and solubility, 
are perceived as both a great source of frustration and intense interest for pharmaceutical 
scientists.  
Piroxicam, (4-Hydroxy-2-methyl-N-(2-pyridinyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-
dioxide) is a potent non-steroidal anti-inflammatory drug (NSAID) that is widely used for 
pain relief in rheumatoid arthritis, osteoarthritis as well as other muscular pain and injuries. 
Its mechanism of action is preventing the production of prostaglandins by non-selectively 
inhibiting the enzymes cyclooxygenase (COX) 1 and 2, which are involved in inflammatory 
and pain responses in the body, and thus provides anti-inflammatory, analgesic and 
antipyretic activity.   
 
Polymorphs of piroxicam were first reported back in 1982 by Mihalic et al. 2  They identified 
two anhydrous piroxicam polymorphs which exist in cubic and needle forms, as well as a 
monohydrate form that appears as yellow prisms. Since then, the polymorphism of piroxicam 
has been widely investigated leading to identification of a total of four anhydrous forms and 
one monohydrate form of piroxicam. While there have been significant efforts devoted to the 
discovery of the polymorphs of piroxicam, the characterisation and nomenclatures of 
piroxicam polymorphs have remained inconsistent and occasionally conflicting3.   
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One of the reasons is that this may be due to the ready phase transition of the sample, leading 
to the miscorrelation between experimental characterisation and a specific polymorphic form. 
Another possible reason would be due to the close polytypic relationship between α1 
(orthorhombic, Pca21, a=11.8, b=17.4, c=7.0) and α2 (monoclinic, P21/c, a=17.6, b=11.9, 
c=7.0, β=97°), where both were erroneously referred to as the single form II by Vrecer et al.4  
Sheth et al. attempted to resolve confusion between the polymorphic forms in a summary of 
reported properties of piroxicam polymorphs with detailed comparison of the hydrogen 
bonding profiles of form I and form II.3 This was reinforced by Upadhyay and Bond with a 
detailed description of crystallisation conditions and other experimental characterisation data 
for piroxicam polymorphs α1 and α2.5  
The US Food and Drug Administration (FDA) has produced some nonbinding 
recommendations in its Guidelines for Industry report6, to assist in assessing what truly 
qualifies as a polymorph. In this guide, polymorphs include crystalline and amorphous forms, 
as well as solvates and hydrates. Bordner et al.7 reported that unlike the previously reported 
structures, it exists in a zwitterionic form, with the enolic hydrogen on O(3) having been 
transferred to the pyridine nitrogen N(3) (Figure 1).  
	  
Figure 1. Structure of piroxicam (4-Hydroxy-2-methyl-N-(2-pyridinyl)-2H-1,2-
benzothiazine-3-carboxamide 1,1-dioxide) (a) and its zwitterionic form (b). 
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The experimental electron density distribution (EDD) of a molecular system obtained from 
high-resolution X-ray diffraction experiments forms a unique physical-chemical method, 
which allows detailed information about the nature of intra- and intermolecular charge 
interaction in the solid state to be obtained. Bader’s Atoms in Molecules (AIM)8 approach 
provides an excellent tool for interpretation of both X-ray determined and theoretical charge 
densities. Analysis of the charge density is based upon the topological properties of the 
density ρ(r), where the topological analysis is based upon those bond critical points (BCP’s) 
where the gradient of the density, ∇ρ, vanishes. Properties evaluated at such points 
characterise the bonding interactions present, and have been widely used to study 
intermolecular interactions. The application of AIM allows not only the network of 
intermolecular contacts to be established, but also permits an estimation of their energy 
through the correlation between the energy and the electron density at the bond critical point.9 
It has been noted that there are a limited number of experimental charge density studies on 
polymorphic systems10,11,12, due in the main to the difficulty in obtaining suitable crystals. In 
an attempt to provide more detailed characterisation of piroxicam polymorphs and to explain 
the difference in physical properties between the polymorphs, we report a comparison of the 
charge density distribution obtained from high-resolution single crystal X-ray diffraction on 
two polymorphs of piroxicam, form I, aka the β-form (1), and the related monohydrate (2). In 
this study, the experimental EDD between the two forms are compared with the aim of 
investigating if the changes in charges can be significant enough to be: (a) accurately 
determined, and (b) what are the structural implications of any charge redistribution.  
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Methods 
Crystal preparation 
Piroxicam was purchased from Sigma-Aldrich and used without further purification. 
Polymorphs (1) and (2) were obtained via slow evaporation from acetone, surprisingly, in the 
same vial.  
X-ray Data Collection, Integration and Reduction  
The single crystal X-ray diffraction experiments were carried out in the Faculty of Pharmacy 
at the University of Sydney using an Agilent SuperNova™ X-ray diffractometer with an X-
ray wavelength of 0.7107 Å (Mo Kα) at 100K. Crystals of (1) and (2) with dimensions (0.30 
x 0.20 x 0.20) mm and (0.25 x 0.15 x 0.15) mm respectively, were mounted onto the tip of a 
thin glass fibre with Paratone-N oil being used as both an adhesive and cryo-protectant. Data 
were collected for all crystals using 1° ω-scans maintaining the crystal-to-detector distance at 
5.2cm for (1) and 5.3 cm for (2). For (1) and (2), reciprocal space coverage was achieved 
during the data collection by positioning the detector arm at two different angles in 2θ, 41.5° 
and 90.5°. Exposure times of 6 and 24 seconds were used for (1), 15 and 30 seconds for (2) 
respectively. A total of 7695, and 4587, frames were collected for (1) and (2) respectively.  
Integration and reduction of the collected data was performed with the CrysAlisPro software 
package.13 All crystals were cooled to 100K with an Oxford Cryosystems COBRA cooler. 
The unit cell parameters for (1) were refined from 198191 reflections in the monoclinic space 
group P21/c with Z=4, F(000) =688 and µ=0.248 mm-1. The unit cell parameters for (2), were 
refined from 456880 reflections in the triclinic space group P  with Z=2, F(000) =728 and 
µ=0.249 mm-1. Refer to Table 1 for selected crystallographic information from the 
independent atom model (IAM) and multipole refinements. Bond lengths and angles, 
1
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temperature factors, coordinates, torsion angles and full hydrogen bond details can be found 
in supporting information tables S1-S12.  
Table 1. Selected crystallographic information for complexes (1) and (2).  
 1 2 
Formula C15H13N3O4S C15H13N3O4S.H2O 
Molecular Mass 331.34 349.34 
Crystal size (mm) 0.25 x 0.20 x 0.20 0.25 x 0.15 x 0.15 
Temperature (K) 100 100 
Crystal system Monoclinic Triclinic 
Space group P21/c P -1 
a (Å) 7.034(1) 10.347(10) 
b (Å) 14.989(1) 12.713(10) 
c (Å) 13.894(1) 12.810(10) 
α (o) 90 102.78(10) 
β (o) 96.38(1) 99.99(10) 
γ (o) 90 108.73(10) 
Volume (Å3) 1455.90(1) 1500.67(2) 
Z 4 4 
Refinement Method Full-matrix least 
squares on F2 
Full-matrix least 
squares on F2 
No. of reflections collected 198191 456880 
No. unique 16911 31885 
Rint 0.045 0.021 
Completeness (%) 95.8 99.6 
No. reflections used 14742 23573 
ρc (gcm-1) 1.512 1.546 
F(000) 688 728 
µ (mm-1) 0.248 0.249 
sin θ/λmax  1.11 Å
-1 1.11 Å-1 
θ range for data collection 
(°) 
2.718 to 65.67 2.763 to 65.17 
Index ranges -17<=h<=18  
-38<=k<=38  
-34<=l<=35 
0<=h<=22 
-28<=k<=26  
-28<=l<=35 
IAM Refinement   
Final R1, wR2 0.034, 0.09 0.040, 0.105 
   
Goodness of fit  1.045 1.061 
Residual density (eÅ-3) -0.739, 0.829  -0.717, 0.678 
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Multipole Refinement   
Nobs/Nvar   
 Exp  
SH_D 
24.1 
24.3 
18.7 
28.6 
R(F), R(F2), all data   
 Exp 
 SH_D 
0.021, 0.031 
0.031, 0.032 
 0.024, 0.026 
0.024, 0.027 
 
Rw(F), Rw(F2) > 2σ(F)   
 Exp 
 SH_D 
0.023, 0.045 
0.026, 0.050  
0.014, 0.029 
0.015, 0.029 
Goodness of fit   
 Exp  
 SH_D 
1.707 
1.696 
1.558 
1.570 
Residual density (eÅ-3)   
Exp  
SH_D 
-0.25 to 0.27 
-0.32 to 0.28 
-0.34 to 0.06 
-0.25 to 0.25 
   
 
Data refinement strategies  
 
The structures of (1) and (2) were solved using direct methods (SHELXT).14 For both, full 
matrix least squares refinement based on F2 was performed using SHELXL-2015.15 The bond 
lengths between non-hydrogen atoms to hydrogen atoms (X-H bonds, where X = C, O, N) 
were fixed at average values determined by neutron diffraction studies, taken from Allen et 
al.,16 non-water O−H, N−H, and C−H bond lengths being 0.967, 1.009, and 1.083 Å 
respectively, with bond vectors taken from the original riding H-atom models in the IAM 
refinement. For the water molecules the O – H bond lengths were fixed at 0.985 Å.17 All non-
hydrogen atoms were refined anisotropically. 
The coordinates and anisotropic temperature factors from the IAM were then imported into 
XD2006,18 a program that utilises a least squares procedure to refine a rigid pseudoatom 
model in the form of the Hansen-Coppens multipole formalism.19 In this formalism, the 
electron density, ρ(r) within a crystal is described by the summation of aspherical 
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pseudoatoms (each with its own electron density) with nuclear positions rj as shown in the 
Equation (1) below: 
 𝜌 𝑟 = 𝑗! 𝜌!(𝑟 − 𝑅!)        (1) 	  
The complete density of the pseudoatomic model is modelled by the following Equation (2):  
𝜌! 𝑟! = 𝑃!𝜌! + 𝜅!"𝑃!𝜌! 𝜅!𝑟 + 𝜅!!"   !!"#!!! 𝑃!"𝑅!
!!!
!!!! (𝜅!!𝑟!)𝑑!"#(𝜃!,𝜙!)	  
   (2) 
The expression for the pseudoatom density includes the usual spherical core, a term to 
describe the spherical component of the valence density, plus a deformation term describing 
the asphericity of the valence density. The radial functions { Rl(rj) } are modulated by 
angular functions { dlmp(θj ,Φj) } defined by axes centred on each atom. A number of radial 
functions may be used, the most common being Slater-type functions given in Equation (3): 
𝑅𝑙 𝑟 = 𝑁𝑟𝑛𝑙   𝑒𝑥𝑝(−𝜁𝑙  𝑟)        (3) 
The multipole refinement process began with an analysis of the results of higher order 
spherical atom refinement (usually sin θ/λ > 0.7A-1), providing accurate atomic positions 
forming the basis for the remainder of the refinement.  
Sulfur and other third row atoms are traditionally modelled by the standard nl-set of 
(4,4,4,4,4), as these were originally modelled using single-ζ functions to model the valence 
density. We and others, have shown that this standard description can be problematic20,21 with 
high residual electron density in the proximity of the sulfur atoms. The nl-set for sulfur used 
here was (4,4,4,5,5)22. In addition, optimisation of the sulfur core electron density distribution 
was achieved by assigning a spherical expansion/contraction coefficient (κ′), to the 1s, 2s and 
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2p electrons, and allowed to refine. The value of ζ for sulfur was that of the free atom (7.278 
Å-1)23. 
As outlined above, it was necessary to optimise the standard description of sulfur in this 
refinement. Each sulfur atom (in individual piroxicam moieties) was split so that the core 
shells (1s2, 2s2, 2p6) has a spherical expansion/contraction coefficient (κ′) and a fixed 
population, while the valence shell (3s2, 3p4) had both spherical and aspherical κ values, as 
well as population refined. The suitability of this model is demonstrated in Table 2, where 
maximum and minimum residual errors are significantly smaller in most cases than those 
obtained from the standard model of sulfur.  
Table 2 details the results of the refined κ values for the sulfur atoms in all three molecules, 
along with the associated monopole populations. For (1), in a standard multipole model 
(MM) refinement, both the spherical and aspherical components of the valence density are 
expanded, when compared to that of the free atom. However, when a core-optimised 
approach is taken, the spherical component of the valence density is expanded, while the 
aspherical valence density is essentially the same when compared to that of the free atom.  
Interestingly, in (2), the situation is somewhat different, despite the similar chemical 
environment of the sulphonyl group. Here the valence density is expanded as is the aspherical 
component, when compared to the free atom. 
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Table 2. Expansion/contraction coefficients (κ) for sulfur. Values in parentheses refer to a 
standard un-optimised (nl =4,4,4,4,4) refinement. 
Atom Label κ´ κ´´ Population (e) R(F) Max/Min 
Residual 
e Å-3 
Piroxicam  
(1) 
     
S(1)valence 0.9498 1.0002  5.8561   
S(1´)core 0.9846 1.0000 10.0000 0.0219 0.27/-0.25 
 (0.9876) (0.9746) (5.7451) (0.0217) (0.34/-0.37) 
Monohydrate 
(2a) 
     
S(1A)valence  0.9479 0.9813  5.5608   
S(1B)core 0. 9479 1.0000 10.0000 0.021 (0.34/-0.06) 
 (0.9848) (0.9132) (5.6523) (0.027) (0.22/-0.35) 
(2b)      
S(1’A)valence  0. 9479 0.9813  5.5142   
S(1’B)core 0. 9479 1.0000 10.0000   
 - - (5.7177)   
 
The refinement proceeded by increasing the level of the multipole expansion in a stepwise 
manner, finally being truncated at the octapole level (lmax = 3) for C, O, N and S. Each C, O, 
N and S atom was assigned a kappa prime (κ′, a spherical function which governs 
expansion/contraction of the valence shell) during the refinement to allow for accurate 
modeling of the electron density, and finally a κ′′ which models the aspherical radial 
expansion/contraction of the valence electrons. The density of hydrogen atoms was modeled 
using a single monopole, with κ′ fixed at 1.2, with the aspherical density modeled by a single 
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bond-directed dipole (lmax = 1). The refinements were continued until convergence was 
reached for each multipole before the next one was introduced. The Hirshfeld rigid bond test 
was used to determine if the anisotropic displacement parameters were of any actual physical 
xsignificance; i.e. has the electron density been successfully deconvoluted from the inherent 
thermal smearing.24 This test measures the differences in mean-squared displacement 
amplitudes (DMSDA) with ADP’s deemed to be described as physically meaningful if they 
are below 1 x 10-3 Å2. The average value obtained from these refinements is 2.6 x 10-4 Å2. 
Scale and temperature factors were refined separately from the multipoles, and only in the 
final cycles were all parameters allowed to refine together, to get the complete variance-
covariance matrix, thus obtaining meaningful su’s. Only reflections with intensity of F > 3σ 
(F) were included in the refinement. This model is termed Exp in the remainder of the 
manuscript. See Figure 2 for molecular structures of β-piroxicam and piroxicam 
monohydrate.  
 
Anisotropic Temperature Factor Refinement of Hydrogen Atoms  
The temperature factors of hydrogen atoms were also anisotropically modelled based upon 
discussions by Hoser et al.,25 Spackman et al.26 and Koritsansky et al.27 These studies have 
observed dissimilarities in the topological analysis of weak interactions such as H-bonds, van 
der Waals forces and π- π stacking interactions.28 To observe the effect of applying calculated 
anisotropic temperature factors for hydrogen atoms during multipole refinement, anisotropic 
temperature factors were calculated29  and the resulting anisotropic displacement parameters 
(ADPs) transferred to the multipole model. This will be termed SH_D for the remainder of 
the manuscript. The anisotropic temperature factors for the hydrogen atoms were calculated 
using the SHADE3 server.29 The multipole analyses with the anisotropic temperature factors 
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for hydrogen were truncated at the same level as above ((lmax = 3) for heavy atoms and up to 
the (lmax = 1) for hydrogen atoms). The multipole refinement for hydrogen atoms was 
capped at the dipolar level of expansion, as in this particular case, when expanded to the 
quadrupolar level, the populations were negligible. Refer to Table S13 in supplementary data 
for the ADPs used. As can be seen from Table 1, there is very little to separate the Exp and 
SH_D refinements, in a similar fashion to recent experiences30,31 with calculated hydrogen 
ADPs in multipole refinements, the SH_D refinement was not able to locate critical points of 
some intramolecular hydrogen bonds and so the topological analysis will be based on the Exp 
refinement.  
Computational Methods  
Gas phase single point (SP) calculations were carried out on (1) and (2), with the geometry 
taken from the high-order experimental coordinates. Calculations were performed with the 
Gaussian 09 suite32 at the 6-311++G(d,p) level of theory for all structures. All calculations 
utilised the CAM-B3LYP33,34,35 which combines the hybrid B3LYP with the long range 
correction of Tawada et al.. Analysis of the topology of electron density from the 
experimental model was performed using the XDPROP module of XD2006,18 while analysis 
of the electron density for the theoretical densities was performed using the AIMALL36 
package.  
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(1) 
 
      (2) 
Figure 2. ORTEP diagram of β-piroxicam (1) and piroxicam monohydrate (2). Thermal 
ellipsoids are shown at 50% probability level.37  
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Results and Discussion 
 
Geometry 
Bond lengths and angles for all experimental structures were obtained from the MM 
refinement output, for (1), the X-ray structure was in excellent agreement with results 
reported by Koji-Prodic et al.38 in 1982, with mean differences of 0.06Å and 0.4° for bond 
lengths and angles, respectively. A similar situation was also seen for (2), where the 
geometrical details obtained from MM refinement were in good agreement with the bond 
lengths and angles reported by Bordner et al.7 with mean differences of 0.12Å for bond 
length and 0.11° for angles, respectively. In the crystal of (2), there are two independent 
molecules of piroxicam, both of which are zwitterionic in nature, where the enolic hydrogen 
(H3A) from O(3) is now found on the pyridyl nitrogen N(3). This has the effect of rotating 
the pyridyl group approximately 180° around the N(2) – C(10) bond (compared to (1)), and 
forms an intra-molecular hydrogen bond with the amide oxygen O(4). The effect of the 
intramolecular hydrogen bond can be seen in the bond lengths of 1.41Å and 1.37Å in (1) and 
(2) respectively for the N(2) – C(10) bond, with the bond in (2) being shorter due to increased 
attraction force between the surrounding atoms pulling the molecule closer together.  Refer to 
Table S2 for (1) and S8 for (2a) and (2b) in supplementary data for a comparison of 
experimental bond lengths and angles.  
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Figure 3. Structure overlays of (1) blue, (2a) green, and (2b) brown. 
 
In (1), the amide and pyridine fragments are essentially co-planar, as determined by theC(9)-
N(2)-C(10)-C(11) torsion angle of -4.01°. In contrast, as noted by Bordner, the zwitterionic 
(2a) in (2) is markedly non-planar (C(1)-C(9)-N(2)-C(10) = 170.1°, see Figure 3, while (2b) 
retains an essentially planar conformation. Our high-resolution data allows us to examine the 
effects of this non-planarity on conjugation across the piroxicam molecule in its different 
polymorphs, along with those associated with the change in protonation state and crystalline 
environment. Properties at selected bond critical points within both forms are reported in 
Table 3 in order to probe these effects. Significant differences in bonding between forms are 
apparent in many bonds: (1) exhibits marked asymmetry in S—O bonds, apparently due to 
intermolecular hydrogen bonding (vide infra), which is not present in (2). In addition, the 
formally double C(2)—C(3) bond is weaker in (2), while C(2)—O(3) is stronger, suggesting 
that charge is substantially redistributed about this group and that formal assignment as an 
enolate in (2) may be problematic. A possible explanation of the stronger C(2) – O(3) bond in 
(2) is the resonance that occurs from the loss of the hydrogen atom to the nitrogen, resulting 
in increased electron density and subsequently increased bond strength. This explanation is 
further strengthened via a study of the bond orders of the C(2) – O(3) bonds and its 
surrounding bonds C(1) – C(2) and C(2) – C(3). According to Bader8, a formal single bond 
should have ε=0.0 and a double bond ε=0.4. The C(1) – C(2) and C(2) – C(3) bonds in both 
(2a) and (2b) have minimally reduced double bond character compared to its counterpart in 
(1), (ε=0.38 and 0.39) respectively for the aforementioned bonds in (2a) and (2b) vs. ε=0.42 
in (1)). Following on from this, the ellipticity of the C(2) – O(3) bond was found to have 
marginally increased double bond character (ε=0.17 and 0.18 in (2a) and (2b) vs. ε=0.15 in 
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(1)) In the situation of the zwitterionic nitrogen. N(3), the addition of the hydrogen seems to 
have had little effect on the bond order or ellipticity (ε= 0.17,0.19 and 0.16 for C(10) – N(3) 
in (1), (2a) and (2b) respectively and ε=0.16. 0.14 and 0.13 for C(14) – N(3) in (1), (2a) and 
(2b)). A similar situation was seen in the theoretical models of (1) and (2), which utilised 
delocalisation indices to determine bond order as discussed by Firme et al.39. Conjugation 
effects appear to be relatively small: C(1) – C(9) and C(9) – N(2) are very similar between 
forms, although N(2) – C(10) is slightly stronger in (2) than in (1). Other than the case of 
C(2) – C(3) noted above, C – C bonds differ little between forms. 
Figures 4(a-d) show the static deformation density maps (defined as: Fcalc, multipole – Fcalc, IAM) 
for (1) and (2a), ((2b) being almost identical). The quality of refinement is reflected in the 
fact that there are no double maxima present in any bonding regions .In Figure 4(a), the 
O(3)–H(3A) can be clearly seen, while there is an intense maxima located on S(1).  In Figure 
4(b), the lone pair region of the pyridyl nitrogen is clearly visible. Of interest also in Figure 
4(b), the polarisation of the lone pair on O(4) can be clearly seen participating in the 
hydrogen bond with H(11). Figure 4(c) is notable as the out-of-plane lone pair of O(3) can be 
seen directed at the amide H(2), however this can been seen more clearly in Figure 4(d), 
where the O(3) lone pairs show clear polarisation toward, this amide hydrogen, and 
additionally, to the H(1W) of the water molecule. 
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  (a)      (b) 
 
  
  (c)      (d) 
Figure 4. Deformation density of (1) (a), (b) and (2a) (c), (d) 
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Topological Analysis 
Topological analysis of both the theoretical and experimental structures density was carried 
out and completeness of the analysis was ensured through satisfaction of the Poincaré-Hopf 
or its crystalline equivalent Morse relationship.40 Table 3 details the topological data for (1) 
and (2). While (1) is a neutral molecule and (2a) and (2b) are zwitterionic, perhaps 
unsurprisingly there is little difference in the values of ρ and ∇2ρ in the bulk of the molecule 
(average difference of 0.10 eÅ-3 and 3.00 eÅ-5 for for ρ and ∇2ρ respectively). Topological 
analysis of the experimental model shows the transfer of this proton results in a difference in 
ρ and ∇2ρ around the O(3) – C(2) bond between (1) and (2a) as well as (1) and (2b). (2a) and 
(2b) has a ρ greater than (1) by 0.487 eÅ-3 and 0.512 eÅ-3 respectively, and a ∇2ρ greater than 
by 12.747 eÅ-5 and 10.451 eÅ-5 respectively. This suggests that the electron density is more 
localised and concentrated around the O(3) – C(2) bond as the electron density is no longer 
shared with enolic hydrogen due to the zwitterionic nature of (2). In the same manner, ρ and 
∇2ρ around the N(3) – C(10) bond is significantly different due to the protonation of the atom. 
The value of ρ around N(3) – C(10) of (2a) and (2b) is 0.086 eÅ-3 and 0.017 eÅ-3 smaller 
than that of (1) respectively, while ∇2ρ around the same bond of (2a) and (2b) is 10.865 eÅ-5 
and 8.644 eÅ-5 smaller than that of (1) respectively. This once again suggests the electron 
density is now shared among N(3) – H(3A) as well as N(3) – C(10). See Table S14a in 
supplementary data for full details of Exp, SH_D and theoretical values for the topological 
analysis. 
 
Table 3. Bond critical point data for selected bonds (all heavy atoms + O-H & N-H) 
Bond ρ ∇2ρ ε 
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/ eÅ-3 / eÅ-5 
S(1)-O(1) (1) 2.390 1.468 0.17 
(2a) 2.246 10.506 0.05 
(2b) 2.193 8.627 0.05 
S(1)-O(2) 1.966 15.86 0.21 
 2.168 11.575 0.08 
 2.289 11.958 0.07 
S(1)-N(1) 1.584 -10.92 0.35 
 1.591 -5.826 0.14 
 1.539 -3.963 0.19 
S(1)-C(8) 1.392 -7.25 0.15 
 1.453 -9.392 0.14 
 1.402 -8.625 0;.13 
O(3)-C(2) 2.060 -18.003 0.15 
 2.547 -30.748 0.17 
 2.572 -28.451 0.18 
O(3)-H(3A) 2.255 -24.804 0.01 
 - - - 
 - - - 
O(4)-C(9) 2.618 -28.284 0.09 
 2.750 -27.384 0.16 
 2.702 -32.154 0.14 
N(1)-C(1) 1.760 -9.325 0.09 
 1.845 -13.831 0.16 
 1.813 12.996 0.14 
N(1)-C(15) 1.622 -8.585 0.12 
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 1.716 -10.497 0.07 
 1.757 -11.204 0.14 
N(2)-C(9) 2.127 -21.430 0.17 
 2.108 -24.344 0.19 
 2.063 -23.611 0.17 
N(2)-C(10) 2.083 -19.742 0.17 
 2.185 -24.406 0.21 
 2.181 -24.189 0.19 
N(2)-H(2A) 2.355 -23.319 0.07 
 2.194 -33.314 0.06 
 2.188 -28.823 0.07 
N(3)-C(10) 2.264 -17.885 0.17 
 2.346 -28.746 0.19 
 2.277 -26.524 0.16 
N(3)-C(14) 2.389 -22.930 0.16 
 2.194 -26.468 0.14 
 2.161 -25.410 0.13 
N(3)-H(3)    
 1.989 -30.811 0.05 
 2.137 -35.185 0.06 
C(1)-C(2) 2.238 -21.422 0.42 
 2.177 -21.804 0.38 
 2.057 -18.055 0.39 
C(1)-C(9) 1.909 -14.883 0.29 
 1.966 -17.923 0.35 
 1.997 -18.336 0.33 
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C(2)-C(3) 1.957 -16.253 0.24 
 1.730 -13.551 0.21 
 1.724 -13.151 0.17 
C(3)-C(4) 2.052 -18.061 0.27 
 2.122 -20.211 0.25 
 2.092 -19.540 0.23 
C(3)-C(8) 1.900 -15.073 0.18 
 2.076 -19.407 0.25 
 2.059 -18.786 0.29 
C(4)-C(5) 2.164 -20.379 0.28 
 2.100 -19.848 0.23 
 2.085 -20.048 0.28 
C(5)-C(6) 1.996 -18.044 0.19 
 2.100 -19.468 0.26 
 2.118 -19.775 0.26 
C(6)-C(7) 2.094 -18.640 0.21 
 2.136 -20.090 0.22 
 2.143 -20.440 0.24 
C(7)-C(8) 2.140 -18.671 0.24 
 2.104 -20.004 0.27 
 2.059  -18.786 0.29 
C(10)-C(11) 2.081 -18.549 0.28 
 2.113 -20.542 0.26 
 2.095 -19.392 0.26 
C(11)-C(12) 2.190 -20.303 0.21 
 2.174 -21.572 0.23 
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 2.140 -20.589 0.26 
C(12)-C(13) 2.007 -16.428 0.19 
 2.100 -19.713 0.17 
 2.047 -18.686 0.19 
C(13)-C(14) 2.147 -19.746 0.23 
 2.253 -24.130 0.26 
 2.236 -23.069 0.27 
 
 
 
  (a)     (b) 
 
   (c)    (d) 
 
Figure 5. Exp -∇2ρbcp distribution of the O(1) – S(1) – O(2) plane for piroxicam in (a) (1), (b) 
(2a), (c) (2b), (d) theoretical for (1).  
 
Overall, the agreement in the topological analysis between experiment and theory is good. 
The difference in ρbcp and ∇2ρbcp values obtained from the Exp and theoretical single point 
densities for both (1) and (2), in non- S-O bonds (excluding bonds to hydrogen atoms), show 
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average differences of -0.05 eÅ-3 and -0.02eÅ-5 and 4.08 eÅ-5 and -1.54 eÅ-5 ρbcp and ∇2ρbcp, 
respectively. 
In the S–O bonds however, agreement between experiment and theory is poor. For (1) the 
largest differences seen are in the topology of the sulfonyl bonds, Density Functional Theory 
(DFT) underestimates ρbcp by 0.34 eÅ-3 in S(1) – O(1), and overestimates this quantity in S(1) 
– O(2) by 0.1 eÅ-3.  Even larger differences in ∇2ρbcp are found, where the experimental 
values are underestimated by 27 and 13 e Å-5 for the same bonds. For (2), the effect on the 
sulfonyl bonds Laplacian values are similar, and differences in ∇2ρbcp values between 
experiment and DFT for the S=O bonds in (2a) were 21 and  19 eÅ-5, while for (2b) the 
values were 23 and 20 eÅ-5. However, interpretation of such values obscured by the rapidly 
changing nature of ∇2ρ within polar covalent bonds, where the BCP is often located close to 
the point where ∇2ρ changes sign. 
Experimental and theoretical -∇2ρ distributions of the O(1)–S(1)–O(2) plane are shown in 
Figures 5(a-d),  with the clear disagreement between experimental and theoretical models is 
both seen in (1) and (2). DFT universally predicts large, positive values of ∇2ρbcp, (d), 
indicative of closed-shell interactions, and the experimental maps show a similar pattern. As 
shown in Figure 5, Laplacian diagrams for S=O bonds in each of the complexes show a clear 
overlap of the valence shell charge concentration, resulting in what appears to be open shell 
interactions, albeit with a severe pinching off in the S(1)–O(2) bond in (2a). This is not 
uncommon in polar bonds, as we have previously noted41  and can be explained by the 
experimental density changing more quickly than the theoretical counterpart. Thus, very 
small differences in the total electron density, of the same magnitude as the residual errors 
stemming from the multipole model, are amplified in the Laplacian into apparently major 
discrepancies between experiment and theory20, 41. 
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Topology of hydrogen bonds 
As well as the non-planarity of (2) compared to (1), the transfer of a proton from O(3) to N(3) 
induces a 180° rotation of the pyridine group and establishes a quite different pattern of intra- 
and intermolecular hydrogen bonding between polymorphs. Details of these hydrogen bonds, 
as determined by properties of the associated bond critical points, are reported in Tables 4 
and 5, for (1) and (2) respectively. Form (1) contains three intramolecular H-bonds of type 
O—H…O, N—H…N and C—H…O. According to the data in Table 4, the former is 
exceptionally strong with very large electron density and positive Laplacian, along with 
negative energy density. Application of Abramov and Espinosa’s method for estimation of H-
bond strengths9,42 results in a very large stabilisation energy of almost 160 kJ mol-1 (38 kcal 
mol-1) for this interaction, placing it at the upper limit of values considered typical for H-
bonds43. The other two intramolecular H-bonds are weaker but still stabilise the planar form 
of (1) by ca. 30 and 50 kJ mol-1, respectively. The method has previously been criticised for 
intramolecular H-bonds31, so complementary DFT calculations were performed. Rotation of 
90° about the C(1)—C(9) bond breaks both the O—H…O and N—H…N H-bonds, but keeps 
the C—H…O contact. This (hypothetical) rotated form of piroxicam is found to be 81 kJ mol-
1 less stable than the true form. This value should contain contributions from disrupted 
conjugation as well as broken H-bonds, and so is likely to be an overestimation of the 
strength of the latter. It is therefore striking that the DFT prediction is approximately half of 
that from electron density, such that we once again call into question the use of Abramov’s 
method for strong intramolecular H-bonds.  Spackman recently broached this subject via an 
analysis of intermolecular interaction energies calculated via the Abramov-Espinosa method 
and the PIXEL method initially introduced by Gavezzoti44. Spackman found that the 
Abramov-Espinosa method often overestimated the strength of interactions45, especially those 
involving heavy atoms such as halogens, whereas the PIXEL methods’ use of interatomic 
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separation to estimate interaction energies correlated significantly better with theoretical 
energies.  
 
Figure 6. Intramolecular interactions in β-piroxicam (1)36.  
Table 4. Topological analysis of hydrogen bonding in (1). Standard uncertainties have been 
omitted from the table for clarity. They are closely scattered around 0.02 eÅ-3 (ρ bcp) and 0.05 
eÅ-5 (∇2ρ bcp).  
 
ρ 
/ eÅ-3 
∇2ρ 
/ eÅ-5 
ε 
G 
/ Eh eÅ-3 
V 
/  Eh eÅ-3 
H 
/  Eh eÅ-3 
EHB 
/ kJ mol-1 
Intramolecular        
N(2) - H(2A) ··· N(1) 0.16 2.18 1.91 0.14 -0.13 0.01 50.57 
O(3) - H(3A) ··· O(4) 0.36 5.03 0.03 0.38 -0.41 -0.03 159.51 
C(11) - H(11) ··· O(4) 0.12 1.60 0.14 0.10 -0.08 0.02 31.12 
Intermolecular        
N(2)–H(2A) ··· O(2)#1 0.07 1.24 0.33 0.07 -0.05 0.02 19.45 
C(5) – H(5) ··· O(2) #2 0.05 0.75 0.43 0.04 -0.03 0.01 11.67 
C(5) – H(5)  ··· O(1) #3 0.04 0.73 0.53 0.04 -0.03 0.01 11.67 
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C(14) – H(14) ··· O(4) #4 0.01 0.43 2.27 0.02 -0.01 0.01 3.89 
C(15) – H(15A) ··· O(1) #5 0.04 0.67 0.09 0.03 -0.02 0.01 7.78 
C(15) – H(15B) ··· O(1) #6 0.05 0.74 0.11 0.04 -0.03 0.01 11.67 
Close Contacts        
C(3) ··· C(12)	  #7 π ···	  π 0.03 0.31 0.46 0.02 -0.01 0.00 3.89 
C(4) ··· C(10)	  #8 π ···	  π 0.04 0.35 3.56 0.02 -0.01 0.01 3.89 
C(5) ··· C(9) #9 C=O ···	  π 0.04 0.34 0.48 0.02 -0.01 0.00 3.89 
H(12) ··· H(6)	  #10 0.01 0.59 0.13 0.03 -0.02 0.01 7.78 
H(11) ··· H(15C)	  #7 0.02 0.32 0.47 0.02 -0.01 0.01 3.89 
#Symmetry operators used to define atoms: 1-x,1-y,-z; 2-x,1/2+y,1/2-z; 3x,1/2-y,-1/2+z; 4-1-x,-
1/2+y,-1/2-z; 5-1+x,y,z; 6-x,1-y,-z; 7-1+x,1/2-y,-1/2+z; 8x,1/2-y,1/2-z; 9x,1/2-y,-1/2+z; 10-
1+x,y,-1+z. 
 
Proton transfer alters the pattern of intramolecular H-bonds markedly, with (2) exhibiting two 
intramolecular N—H…O interactions within each of the two independent piroxicam 
molecules. These bonds are predicted to be very strongly stabilising on the basis of density 
properties at the corresponding bond critical points. Application of Abramov and Espinosa’s 
method predicts H-bond strengths of 66 and 112 kJ mol-1 for N(3)—H(3)…O(4) and N(2)—
H(2)…O(3), respectively, again placing them at the upper end of typical stabilisation 
energies. Interestingly, these values in (2b) are 58 and 159 kJ mol-1 for N(3’)—H(3’)…O(4’) 
and N(2’)—H(2’)…O(3’), respectively. While the difference of -8 kJ mol-1 for the first of 
these could be down to the very subtle geometric differences, the -47 kJ mol-1 difference in 
the latter bonds may possibly be attributed to O(3) participating in two additional strong 
hydrogen bonds; the intermolecular interaction within the asymmetric unit O(1W)–
H(1W)…O(3) (51 kJ mol-1), and C(15)–H(15A)…O(3) (113 kJ mol-1) between molecules in 
adjacent unit cells. Overall, these assignments are supported by DFT, from which we predict 
destabilisation due to rotation about relevant bonds ( C(10)—N(2) and C(1)—C(9) ) of 104 
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and 166 kJ mol-1, in better agreement with the Abramov predictions. It is interesting to note 
that both prediction methods suggest stronger interaction between the (formally) neutral 
N(2)—H(2) and negative O(3), than between the cationic N(3)—H(3) and neutral O(4), in 
line with the shorter H…O distance in the former. It must be noted here that (2) has a far 
greater number of interactions in total, and this will be discussed in the next section. 
The distribution of charge in the two forms of piroxicam, and any relation to the formal 
charges expected of neutral and zwitterionic forms, which ultimately gives rise to this 
difference is discussed in more detail below. 
 
 
Figure 7. Intra- and intermolecular interactions in piroxicam monohydrate (2)36.  
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Table 5. Topological analysis of hydrogen bonding in (2). Standard uncertainties have been 
omitted from the table for clarity. They are closely scattered around 0.02 e Å-3 (ρ bcp) and 
0.05 e Å-5 (∇2ρ bcp). 
 
ρ 
/ eÅ-
3 
∇2ρ 
/ eÅ-5 
ε 
G 
/ Eh eÅ-3 
V 
/  Eh eÅ-
3 
H 
/  Eh eÅ-
3 
EHB 
/ kJ mol-
1 
Intramolecular        
N(3) - H(3) ··· O(4) 0.20 2.71 0.04 0.18 -0.17 0.01  66.14 
N(2) - H(2) ··· O(3) 0.27 4.66 0.15 0.31 -0.29 0.02 112.82 
N(3’) - H(3’) ··· O(4’) 0.17 2.39 0.12 0.16 -0.15 0.01  58.35 
N(2’) - H(2’) ··· O(3’) 0.35 5.62 0.06 0.40 -0.41 -0.01 159.51 
        
Asymmetric unit 
intermolecular      
  
C(15’) - H(15E) ··· O(1) 0.05 0.53 0.24 0.03 -0.02 0.01 7.78 
C(15’) - H(15F) ··· O(2) 0.02 0.33 0.56 0.01 -0.01 0.00 3.89 
C(7) - H(7) ··· C(15’) 0.03 0.34 0.96 0.02 -0.01 0.00 3.89 
O(1W) - H(1W) ··· O(3) 0.09 4.52 0.58 0.22 -0.13 0.09 50.57 
O(2W) - H(3W) ··· O(1W) 0.11 2.92 0.05 0.16 -0.11 0.05 42.79 
C(11) - H(11) ··· O(2W) 0.05 0.82 0.69 0.04 -0.03 0.01 11.67 
        
Intermolecular        
C(15)-H(15A)...O(3) 0.28 4.38 0.05 0.3 -0.29 0.00 112.83 
O(1W)-H(1W)...O(4) 0.11 3.25 0.13 0.17 -0.12 0.05 46.69 
O(2W)-H4(W)...O(1W) #1 0.11 3.252 0.13 0.17 -0.12 0.05 46.69 
N(3)-H(3)..O(4’) #2 0.11 1.648 0.05 0.1 -0.08 0.02 31.12 
N(3)-H(3)…O(2’) #3 0.07 1.023 0.39 0.06 -0.05 0.01 19.45 
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C(14)-H(14)…N(1’) #2 0.03 0.569 1.36 0.03 -0.02 0.01 7.78 
C(14’)-H(14’)…O(4) #2 0.05 0.722 0.27 0.04 -0.03 0.01 11.67 
C(14’)-H(14’)…N(1) #2 0.01 1.205 0.00 0.06 -0.03 0.03 11.67 
        
Close contacts        
C(11)…C(4’) #3 0.03 0.32 0.29 0.02 -0.01 0.00 3.89 
 0.03 0.31 1.96 0.02 -0.01 0.00 3.89 
C(4’)…C(10’) #4 0.03 0.34 2.47 0.02 -0.02 0.00 7.78 
 0.04 0.34 0.89 0.02 -0.02 0.00 7.78 
C(12’)…O(1’) #5 0.05 0.72 0.86 0.04 -0.03 0.01 11.67 
 0.05 0.714 0.07 0.04 -0.03 0.01 11.67 
C(12)…O(3’) #3 0.06 0.790 0.11 0.05 -0.04 0.01 15.56 
 0.06 0.772 1.02 0.04 -0.03 0.01 11.67 
C(13)…O(3’) #3 0.06 0.79 1.16 0.05 -0.04 0.01 15.56 
 0.06 0.772 1.02 0.04 -0.03 0.01 11.67 
C(7’)…O(1) #3 0.05 0.752 1.16 0.04 -0.03 0.01 11.67 
 0.03 0.448 0.26 0.02 -0.02 0.01 7.78 
C(14’)…O(4) #2 0.06 0.910 0.23 0.05 -0.04 0.01 15.56 
 0.04 0.549 0.16 0.03 -0.02 0.01 7.78 
C(15)…H(14’) #2 0.04 0.667 0.00 0.05 -0.02 0.01 7.78 
 0.01 1.571 0.00 0.07 -0.04 0.04 15.56 
C(7)…H(15B) #6 0.05 0.508 3.86 0.03 -0.02 0.01 7.78 
 0.05 0.521 0.86 0.03 -0.02 0.01 7.78 
#Symmetry operators used to define atoms: 11-x,3-y,1-z; 21+x,1+y,z; 31-x,2-y,-z; 41-x,1-y,-z; 
5x,-1+y,z; 6 2-x,2-y,1-z. 
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Figure 8. Hirshfeld surfaces for (1) (a), (b) and (2) (c), (d). 
	    
   (a)     (b) 
Figure 9. Hydrogen bonds and close contacts in (1), (a), and (2), (b).46 
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The differences in the molecular interactions outlined above can be seen using Hirshfeld 
surfaces.47,48  Figures 8(a-d), and 9(a-b) show the Hirshfeld surfaces and the associated 
hydrogen bonding and close contacts in (1) and (2), with dnorm for the opposing aspects of (1) 
and (2).  The dnorm surfaces highlight contacts that are less than the sum of atomic van der 
Waals radii (red), longer, (blue) and approximately equal, (white). From Figures 8 and 9, it is 
clear to see that both the greater number and strengths of the inter- and intramolecular 
contacts occur in (2). Interestingly, in (1), the shortest and strongest intermolecular contacts 
involve O(1) and O(2) of the benzothiazinecarboxamide and N(2)-H(2A), while in (2) the 
contacts have effectively been eliminated due to the close packing of the two piroxicam 
moieties. These have been replaced as the strongest bonding atoms in (2), by O(4) and O(4’), 
and the two water molecules, one of which O(1W) bridges between (2a), and the second 
O(2W), that forms a strong bond to a piroxicam molecule in an adjoining unit cell.  
Atomic Charges 
 
Atomic charges, evaluated both from monopole populations (Pv) and through integration 
over atomic basins (Bader charges) (Ω), are reported in Table 6 for selected atoms. As with 
bond properties, major changes in atomic charge are found across the molecule: S becomes 
more positive, and O(1) and O(2) more equal, in (2) compared to (1). O(3), which is formally 
a negative enolate in (2), is actually slightly less negative in the zwitterionic form than in (1), 
while the protonated N(3) is significantly more negative in the zwitterion than it is in the 
neutral form. Other large changes are seen in O(4), C(2), and all carbons in the pyridine ring. 
Clearly, these data do not follow the patterns that would be expected on consideration of 
formal charges and protonation states. To examine these changes in more detail, we have 
summed individual atomic charges into fragment values for i) pyridine/pyridinium, ii) amide, 
and iii) benzothiazinecarboxamide fragments. Using the experimental, integrated atomic 
charge data, these fragments in (1) are found to have charges of +0.57, -0.70 and +0.09, 
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respectively; in (2), these values change to +1.30, -0.62, and -0.66. Thus, proton transfer does 
indeed lead to a much more positive pyridinium fragment, but this positive charge is 
delocalised over the entire ring rather than being concentrated on the N—H group. Similarly, 
the benzothiazinecarboxamide fragment is more negative in the zwitterion, but this is not 
localised on the enolate group. 
 
Table 6. Atomic charges (e) from multipole refinement. 
Atom Pv (Exp) Ω (Exp) Ω (dft) 
S(1) (1)           
(2a) 
(2b) 
0.24 
0.39 
0.48 
2.92 
2.98 
3.08 
3.14 
3.19 
3.19 
O(1) -0.39 
-0.44 
-0.42 
-1.59 
-1.45 
-1.39 
-1.34 
-1.36 
 -1.37 
O(2) -0.43 
-0.43 
-0.49 
-1.40 
-1.39 
-1.50 
-1.38 
-1.38 
-1.37 
O(3) -0.32 
-0.34 
-0.34 
-1.08 
-0.97 
-1.06 
-1.18 
-1.25 
-1.23 
O(4) -0.34 
-0.29 
-0.34 
-1.02 
-1.16 
-1.15 
-1.20 
-1.23 
-1.23 
N(1) -0.32 
-0.31 
-0.31 
-1.21 
-1.24 
-1.25 
-1.32 
-1.33 
-1.34 
N(2) -0.19 
-0.20 
-1.13 
-1.26 
-1.28 
-1.29 
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-0.22 -1.26 -1.30 
N(3) -0.11 
-0.17 
-0.15 
-0.82 
-1.27 
-1.28 
-1.22 
-1.35 
-1.35  
C(1) 0.00 
0.01 
0.03 
0.17 
0.22 
0.25 
0.32 
0.28 
0.28 
C(2) 0.06 
0.05 
0.00 
0.48 
0.82 
0.79 
0.63 
0.85 
0.87 
C(3) 0.09 
0.04 
0.05 
0.09 
0.02 
0.05 
0.02 
0.00 
 0.00 
C(4) 0.09 
-0.02 
-0.03 
0.05 
-0.01 
-0.07 
0.02 
-0.02 
-0.03 
C(5) 0.09 
0.04 
0.03 
0.04 
0.05 
0.04 
0.01 
-0.03 
-0.04 
C(6) 0.13 
-0.01 
0.08 
0.10 
-0.04 
0.07 
0.01 
-0.03 
-0.04 
C(7) 0.03 
-0.10 
0.05 
0.01 
-0.12 
0.05 
0.03 
-0.02 
 -0.01 
C(8) -0.04 
-0.12 
-0.11 
-0.17 
-0.27 
-0.25 
-0.15 
-0.16 
-0.15 
C(9) 0.17 1.19 1.45 
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0.10 
0.07 
1.34 
1.25 
1.39 
1.36 
C(10) 0.01 
0.13 
0.14 
0.61 
0.91 
0.94 
0.94 
1.03 
1.06  
C(11) 0.15 
0.02 
0.01 
0.15 
0.01 
0.02 
0.01 
-0.01 
 -0.01 
C(12) -0.06 
0.07 
0.06 
-0.07 
0.10 
0.05 
0.01 
-0.01 
 -0.01 
C(13) 0.02 
0.07 
0.08 
-0.07 
0.11 
0.10 
0.00 
 -0.01 
-0.01 
C(14) 0.14 
0.04 
0.04 
0.56 
0.34 
0.35 
0.58 
0.46 
0.46 
C(15) -0.04 
-0.27 
-0.03 
0.10 
0.05 
0.15 
0.40 
0.31 
0.30 
H(2) -0.03 
0.25 
0.20 
0.26 
0.54 
0.46 
0.47 
0.55 
0.56 
H(3) 0.14 
0.35 
0.31 
0.48 
0.59 
0.59 
0.66 
0.55 
0.54 
H(4) 0.18 
0.14 
0.10 
0.24 
0.15 
0.13 
0.05 
0.08 
0.10 
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H(5) 0.18 
0.06 
0.06 
0.25 
0.07 
0.07 
0.02 
0.06 
0.05 
H(6) 0.08 
0.16 
0.02 
0.12 
0.20 
0.05 
0.02 
0.06 
0.05 
H(7) 0.10 
0.13 
0.09 
0.14 
0.14 
0.14 
0.06 
0.01 
0.01 
H(11) -0.03 
0.06 
0.04 
-0.02 
0.07 
0.11 
0.08 
0.15 
0.12 
H(12) 0.12 
0.08 
0.08 
0.14 
0.10 
0.12 
0.02 
0.13 
0.01 
H(13) 0.07 
0.15 
0.05 
0.14 
0.18 
0.09 
0.01 
0.09 
0.09 
H(14) -0.05 
0.12 
0.14 
-0.05 
0.18 
0.19 
0.02 
0.12 
0.12 
H(15A) 
 
H(15D) 
0.07 
0.08 
0.03 
0.04 
0.05 
0.06 
0.01 
0.04 
0.03 
H(15B) 
 
H(15E) 
0.16 
0.10 
0.10 
0.18 
0.07 
0.11 
0.03 
0.07 
0.08 
H(15C) 
 
0.13 
-0.00 
0.13 
-0.04 
0.01 
0.01 
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H(15F) 0.03 0.02 0.04 
 
Table 7 details the atoms with the greatest differences in charge between (1) and (2). While 
no clear trend is observed between the monopole and Bader charges, there are some 
interesting changes. Considering first the monopole charges, when moving from (1) to (2a) 
C(15) becomes slightly more negative, this can be accounted for by C(15) participating in 
fewer intermolecular contacts in (2a). This effect is also clearly seen in the increased positive 
charge on C(15) between (2a) and (2b). In (2b) S(1) becomes slightly more positive, possible 
due to the fact that O(1) and O(2) are involved in a greater number of intermolecular 
contacts, increasing the polarisation between the sulfur and oxygen atoms. This is clearly 
seen in Figure 5(c). Surprisingly, when considering the experimental Bader charges, the 
largest increase is that of N(3) becoming more negative in both (2a) and (2b) compared to 
(1). As has been discussed, what should be a formally positive nitrogen in zwitterionic (2a,b), 
once again lends support to the delocalisation of the positive charge across the pyridine 
group. In a similar fashion DFT predicts that in moving to a zwitterionic structure that the 
enolate carbon C(2) becomes increasingly positively charged, indicating that enolate has little 
to do with the delocalised negative charge across the benzothiazinecarboxamide. 
 
Table 7. Greatest differences in Atomic charges (e), between molecule pairs and the atoms 
involved.  
(1) and (2a) ΔPv -0.23 C(15) 
ΔΩ(Exp) -0.45 N(3) 
Δ(DFT) +0.22 C(2) 
(1) and (2b) ΔPv +0.24 S(1) 
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ΔΩ(Exp) -0.46 N(3) 
ΔΩ(DFT) +0.24 C(2) 
(2a) and (2b) 
 
 
ΔPv +0.24 C(15) 
ΔΩ(Exp) +0.17 C(7) 
ΔΩ(DFT) -0.03 C(9)  
 
 
Electrostatic Potential 
 
The changes in atomic charges found across the molecule are also reflected in the molecular 
electrostatic potential (MEP) as shown in Figure 10. In the experimental electrostatic 
potential of (2), the pyridyl nitrogen is more electropositive compared to (1). Similarly, the 
enolate group is slightly more electropositive in the zwitterion.  A strong green colour of the 
pyridine ring in the zwitterion shows the ring is more electropositive compared to that in (1) 
and this once again suggests the positive charge from the protonation is distributed over the 
pyridine ring instead of localised on the N—H group. Likewise, the slightly less positive 
benzothiazinecarboxamide fragment in the zwitterion indicates once again that the negative 
charge from the proton transfer in the zwitterion is not concentrated on the enolate group. An 
additional reason for the reduced electron concentration in the benzothiazinecarboxamide 
fragment may be attributed to the water molecules in (2) drawing electrons away from O(4) 
as can be seen by the highly electropositive region in the hydrogen bond between O(4) and 
H(1W).  
A comparison of the electrostatic potential of the N-methyl and sulfoxide groups in (1) and 
(2) show no major differences between them even though the groups in (2) are significantly 
closer to other atoms and thus have a higher potential to form potential bonds. This lack of 
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change in this group between the two polymorphic forms may be attributed to the inherent 
stability of these two functional groups and the fact that their relative geometries are almost 
identical in all three cases. This feature could potentially be utilised in future drug design as 
potential anchors around which other connections may be formed while they remain constant.   
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Figure 10. Electrostatic potential of (1) (a), and (2) (b) plotted on the ρ isosurface49. 
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The differences in hydrogen bonding and molecular polarity between forms (1) and (2) are 
likely to have a significant effect on pharmaceutically relevant properties such as stability and 
solubility. Using ab initio calculations, it has been noted by Sheth et al.3 that it is the 
difference in lattice energy and not the conformational energy of individual molecules, 
(determined to be 0.96 kJ mol-1 for each polymorph), that accounts for the observed 
differences in physical properties. Further, Sheth et al.50 note that the energies of individual 
molecules in the monohydrate form are 50-58 kJ mol-1 greater than in β-piroxicam, which 
would be expected to destabilise the crystal lattice. To examine this in more detail, lattice 
energies were calculated for both forms using the LATEN option in XD2006, which is based 
on total intermolecular interactions energies suggested by Volkov and Coppens.51 In this 
manner, we predict the lattice energy for (1) to be -304 kJ mol-1, while that for (2) is -571 kJ 
mol-1. The observation that the zwitterionic, monohydrated form of piroxicam has a larger 
lattice stabilisation (and thus is thermodynamically more stable) is perhaps not a surprise, 
given the number and strengths of the hydrogen bonding network outlined above. 
Surprisingly, this can be seen when examining the dipole moment. Sheth et al.50 again report 
that the gas-phase molecular dipole moment increases when moving from the β-piroxicam 
structure to the piroxicam monohydrate structure (Δµ ~8D). Calculation of the in-crystal 
molecular dipole moment reveals that the β-piroxicam has a dipole moment of 10.14D, while 
the monohydrate has a marginally smaller MDM of 9.47D. Clearly the water molecules 
present in the monohydrate lattice stabilise the zwitterion, and therefore lower the free energy 
of the molecules via hydrogen bonding network formation. Accurate quantification of this 
effect allows a deeper understanding of the physical properties of this drug. Paaver et al.52 
reports that form (1) displays faster rate of dissolution and greater solubility than (2) at 
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different pHs. This agrees with the lattice energies calculated as lattice energy has a direct 
correlation to dissolution rate and solubility. 
 
Conclusion 
 
In this study we demonstrated the differences between β-piroxicam and piroxicam 
monohydrate by carrying out experimental charge density studies. The presence of water 
molecules in piroxicam monohydrate crystal results in the formation of a zwitterionic 
structure with a concomitant rotation of the pyridine ring, resulting in the formation of a 
number of strong hydrogen bonds that aids the stabilisation of this crystal. Lower solubility 
and higher stability of the monohydrate polymorph are explained by a larger numbers of, and 
stronger interactions inside the crystal. Key to this stabilisation is water molecules, their 
ability to stabilise the zwitterionic piroxicam leads to a higher lattice energy compared to β-
piroxicam. Furthermore, electrostatic potential of the zwitterionic monohydrate has also 
demonstrated the charges caused by proton transfer are not localised and concentrated on the 
atoms involved but are spread and re-distributed across different sections of the piroxicam 
molecule, suggesting chemistry might be different to what we assumed previously. The study 
of polymorphism in piroxicam provides us knowledge on the behaviour of zwitterionic 
molecules and therefore gives us potential insights into new methods available which may 
benefit efforts in crystal engineering. 
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